Full Press Release Details
SOUTH SAN FRANCISCO, Calif., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company focused on discovering and developing novel therapeutics for the treatment of fibrosis, today announced that Bernard Coulie, M.D., Ph.D., President and Chief Executive Officer of Pliant, will present a company update as part of the 41st Annual J.P. Morgan Healthcare Conference.
41st Annual J.P. Morgan Healthcare Conference (January 9-12, 2023)
| Presentation Date/Time: | January 10, 2023, at 7:30 a.m. PT/ 10:30 a.m. ET |
| Venue: | Elizabethan Room D The Westin St. Francis San Francisco San Francisco, California |
Interested parties can access the company presentation from the Investor Relations’ Events & Presentation page of Pliant’s website at https://ir.pliantrx.com/news-and-events/events-and-presentations with an audio archive available for 30 days from the time it is made available.
About Pliant Therapeutics, Inc.
Investor and Media Contact:
Vice President, Investor Relations and Corporate Communications
Pliant Therapeutics, Inc.